Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis

Design and validation of a histological scoring system for nonalcoholic fatty liver disease†

Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791 · see citing works

Inflammation and metabolic disorders

Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · see citing works

Toll-like receptor signalling

Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312 · see citing works

Extracellular vesicles: Exosomes, microvesicles, and friends

Raposo, G., & Stoorvogel, W. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201211138 · Cited by 8,099 · see citing works

Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes

Özcan, U., Cao, Q., Yilmaz, E., Lee, A.-H., Iwakoshi, N. N., Özdelen, E., Tuncman, G., Görgün, C., Glimcher, L. H., & Hotamisligil, G. S. (2004) · Science · doi:10.1126/science.1103160 · Cited by 3,844 · see citing works

Mutation of the mouse klotho gene leads to a syndrome resembling ageing

Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837 · see citing works

TLR4 links innate immunity and fatty acid-induced insulin resistance

Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690 · see citing works

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604 · see citing works

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416 · see citing works

A central role for JNK in obesity and insulin resistance

Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359 · see citing works

Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy

Czabotar, P. E., Lessene, G., Strasser, A., & Adams, J. M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3722 · Cited by 3,219 · see citing works

Nonalcoholic Steatohepatitis

Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903 · see citing works

Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012

Galluzzi, L., Vitale, I., Abrams, J. M., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., Dawson, T. M., Dawson, V. L., El-Deiry, W. S., Fulda, S., et al. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.96 · Cited by 2,421 · see citing works

The plasma lecithin:cholesterol acyltransferase reaction

Glomset, J. A. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43114-1 · Cited by 2,409 · see citing works

Nonalcoholic Fatty Liver Disease

Rinella, M. E. (2015) · JAMA · doi:10.1001/jama.2015.5370 · Cited by 2,289 · see citing works

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): A multicentre, randomised, placebo-controlled trial

Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237 · see citing works

Safety and antitumor activity of recombinant soluble Apo2 ligand

Ashkenazi, A., Pai, R. C., Fong, S., Leung, S., Lawrence, D. A., Marsters, S. A., Blackie, C., Chang, L., McMurtrey, A. E., Hebert, A., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6926 · Cited by 2,213 · see citing works

Human Fatty Liver Disease: Old Questions and New Insights

Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011) · Science · doi:10.1126/science.1204265 · Cited by 2,089 · see citing works

Triglyceride accumulation protects against fatty acid-induced lipotoxicity

Listenberger, L. L., Han, X., Lewis, S. E., Cases, S., Farese, R. V., Ory, D. S., & Schaffer, J. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630588100 · Cited by 2,075 · see citing works

Programmed Cell Death in Animal Development and Disease

Fuchs, Y., & Steller, H. (2011) · Cell · doi:10.1016/j.cell.2011.10.033 · Cited by 1,915 · see citing works

Four deaths and a funeral: from caspases to alternative mechanisms

Leist, M., & Jäättelä, M. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35085008 · Cited by 1,585 · see citing works

Involvement of Toll-like Receptors 2 and 4 in Cellular Activation by High Mobility Group Box 1 Protein

Park, J. S., Svetkauskaite, D., He, Q., Kim, J., Strassheim, D., Ishizaka, A., & Abraham, E. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306793200 · Cited by 1,560 · see citing works

JNK signaling in apoptosis

Dhanasekaran, D. N., & Reddy, E. P. (2008) · Oncogene · doi:10.1038/onc.2008.301 · Cited by 1,529 · see citing works

A lipidomic analysis of nonalcoholic fatty liver disease

Puri, P., Baillie, R. A., Wiest, M. M., Mirshahi, F., Choudhury, J., Cheung, O., Sargeant, C., Contos, M. J., & Sanyal, A. J. (2007) · Hepatology · doi:10.1002/hep.21763 · Cited by 1,338 · see citing works

Endoplasmic reticulum stress in liver disease

Malhi, H., & Kaufman, R. J. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.11.005 · Cited by 1,178 · see citing works

Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis

Feldstein, A. E., Canbay, A., Angulo, P., Taniai, M., Burgart, L. J., Lindor, K. D., & Gores, G. J. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00907-7 · Cited by 1,085 · see citing works

A Subpopulation of Macrophages Infiltrates Hypertrophic Adipose Tissue and Is Activated by Free Fatty Acids via Toll-like Receptors 2 and 4 and JNK-dependent Pathways

Nguyen, M. T. A., Favelyukis, S., Nguyen, A.-K., Reichart, D., Scott, P. A., Jenn, A., Liu-Bryan, R., Glass, C. K., Neels, J. G., & Olefsky, J. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706762200 · Cited by 1,035 · see citing works

Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis

Yamaguchi, K., Yang, L., McCall, S. J., Huang, J., Yu, X. X., Pandey, S., Bhanot, S., Monia, B. P., Li, Y.-X., & Diehl, A. M. (2007) · Hepatology · doi:10.1002/hep.21655 · Cited by 1,019 · see citing works

Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance

Pal, D., Dasgupta, S., Kundu, R., Maitra, S., Das, G., Mukhopadhyay, S., Ray, S., Majumdar, S. S., & Bhattacharya, S. (2012) · Nature Medicine · doi:10.1038/nm.2851 · Cited by 922 · see citing works

CHOP Is Involved in Endoplasmic Reticulum Stress-induced Apoptosis by Enhancing DR5 Expression in Human Carcinoma Cells

Yamaguchi, H., & Wang, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406933200 · Cited by 825 · see citing works

Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells

Wei, Y., Wang, D., Topczewski, F., & Pagliassotti, M. J. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00644.2005 · Cited by 736 · see citing works

Free Fatty Acids Induce JNK-dependent Hepatocyte Lipoapoptosis

Malhi, H., Bronk, S. F., Werneburg, N. W., & Gores, G. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510660200 · Cited by 724 · see citing works

Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease

ARAYA, J., RODRIGO, R., VIDELA, L. A., THIELEMANN, L., ORELLANA, M., PETTINELLI, P., & PONIACHIK, J. (2004) · Clinical Science · doi:10.1042/cs20030326 · Cited by 700 · see citing works

Gene expression of tumor necrosis factor α and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients

Crespo, J., Cayón, A., Fernández-Gil, P. L., Hernández‐Guerra, M., Mayorga, M., Domínguez‐Díez, A., Fernández-Escalante, J. C., & Pons‐Romero, F. (2001) · Hepatology · doi:10.1053/jhep.2001.29628 · Cited by 693 · see citing works

Obesity-Induced CerS6-Dependent C16:0 Ceramide Production Promotes Weight Gain and Glucose Intolerance

Turpin-Nolan, S. M., Nicholls, H. T., Willmes, D. M., Mourier, A., Brodesser, S., Wunderlich, C. M., Mauer, J., Xu, E., Hammerschmidt, P., Brönneke, H. S., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.08.002 · Cited by 693 · see citing works

Life and death by death receptors

Guicciardi, M. E., & Gores, G. J. (2009) · The FASEB Journal · doi:10.1096/fj.08-111005 · Cited by 689 · see citing works

Regulation of metabolism by the innate immune system

Lackey, D. E., & Olefsky, J. M. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.189 · Cited by 667 · see citing works

Membrane lipid saturation activates endoplasmic reticulum unfolded protein response transducers through their transmembrane domains

Volmer, R., van der Ploeg, K., & Ron, D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217611110 · Cited by 655 · see citing works

JNK Expression by Macrophages Promotes Obesity-Induced Insulin Resistance and Inflammation

Han, M. S., Jung, D. Y., Morel, C., Lakhani, S. A., Kim, J. K., Flavell, R. A., & Davis, R. J. (2012) · Science · doi:10.1126/science.1227568 · Cited by 635 · see citing works

Ceramides – Lipotoxic Inducers of Metabolic Disorders

Chaurasia, B., & Summers, S. A. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.07.006 · Cited by 620 · see citing works

Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism

Hanada, K. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(03)00059-3 · Cited by 618 · see citing works

Complexity of Danger: The Diverse Nature of Damage-associated Molecular Patterns

Schaefer, L. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.619304 · Cited by 618 · see citing works

Activation and Dysregulation of the Unfolded Protein Response in Nonalcoholic Fatty Liver Disease

Puri, P., Mirshahi, F., Cheung, O., Natarajan, R., Maher, J. W., Kellum, J. M., & Sanyal, A. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.10.039 · Cited by 596 · see citing works

Lipid homeostasis, lipotoxicity and the metabolic syndrome

Unger, R. H., Clark, G. O., Scherer, P. E., & Orci, L. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.10.006 · Cited by 595 · see citing works

Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways

Huang, S., Rutkowsky, J. M., Snodgrass, R. G., Ono‐Moore, K. D., Schneider, D. A., Newman, J. W. I., Adams, S. H., & Hwang, D. H. (2012) · Journal of Lipid Research · doi:10.1194/jlr.d029546 · Cited by 593 · see citing works

Chronic Palmitate But Not Oleate Exposure Induces Endoplasmic Reticulum Stress, Which May Contribute to INS-1 Pancreatic β-Cell Apoptosis

Karaskov, E., Scott, C. C., Zhang, L., Teodoro, T., Ravazzola, M., & Volchuk, A. (2006) · Endocrinology · doi:10.1210/en.2005-1494 · Cited by 573 · see citing works

Mixed-lineage kinase control of JNK and p38 MAPK pathways

Gallo, K. A., & Johnson, G. L. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm906 · Cited by 572 · see citing works

Opposing unfolded-protein-response signals converge on death receptor 5 to control apoptosis

Lu, M., Lawrence, D. A., Marsters, S. A., Acosta‐Alvear, D., Kimmig, P., Mendez, A. S., Paton, A. W., Paton, J. C., Walter, P., & Ashkenazi, A. (2014) · Science · doi:10.1126/science.1254312 · Cited by 569 · see citing works

Distinct Effects of Saturated and Monounsaturated Fatty Acids on β-Cell Turnover and Function

Maedler, K., Spinas, G. A., Dyntar, D., Moritz, W., Kaiser, Ν., & Donath, M. Y. (2001) · Diabetes · doi:10.2337/diabetes.50.1.69 · Cited by 552 · see citing works

Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis

Argo, C. K., Northup, P. G., Al‐Osaimi, A. M. S., & Caldwell, S. H. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.03.019 · Cited by 551 · see citing works

Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease

Malhi, H., & Gores, G. J. (2008) · Seminars in Liver Disease · doi:10.1055/s-0028-1091980 · Cited by 537 · see citing works

Saturated Fatty Acid and TLR Signaling Link β Cell Dysfunction and Islet Inflammation

Eguchi, K., Manabe, I., Tanaka, Y., Ohsugi, M., Kono, N., Ogata, F., Yagi, N., Ohto, U., Kimoto, M., Miyake, K., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.01.023 · Cited by 520 · see citing works

Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes

Hirsova, P., Ibrahim, S. H., Krishnan, A., Verma, V. K., Bronk, S. F., Werneburg, N. W., Charlton, M., Shah, V. H., Malhi, H., & Gores, G. J. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.12.037 · Cited by 510 · see citing works

PKC-θ knockout mice are protected from fat-induced insulin resistance

Kim, J. K., Fillmore, J. J., Sunshine, M. J., Albrecht, B., Higashimori, T., Kim, D.-W., Liu, Z.-X., Soos, T. J., Cline, G. W., O’Brien, W. R., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422230 · Cited by 500 · see citing works

A Liver Full of JNK: Signaling in Regulation of Cell Function and Disease Pathogenesis, and Clinical Approaches

Seki, E., Brenner, D. A., & Karin, M. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.004 · Cited by 488 · see citing works

JNK- and p38 kinase-mediated phosphorylation of Bax leads to its activation and mitochondrial translocation and to apoptosis of human hepatoma HepG2 cells

Kim, B.-J., Ryu, S.-W., & Song, B.-J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510644200 · Cited by 470 · see citing works

CerS2 Haploinsufficiency Inhibits β-Oxidation and Confers Susceptibility to Diet-Induced Steatohepatitis and Insulin Resistance

Raichur, S., Wang, S. T., Chan, P. W., Li, Y., Ching, J., Chaurasia, B., Dogra, S. K., Öhman, M. K., Takeda, K., Sugii, S., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.09.015 · Cited by 456 · see citing works

Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition

Charlton, M., Krishnan, A., Viker, K., Sanderson, S. O., Cazanave, S. C., McConico, A. L., Masuoko, H., & Gores, G. J. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00145.2011 · Cited by 444 · see citing works

Hepatic Lipid Partitioning and Liver Damage in Nonalcoholic Fatty Liver Disease

Li, Z.-Z., Berk, M. P., McIntyre, T. M., & Feldstein, A. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807616200 · Cited by 401 · see citing works

Lipoapoptosis in Beta-cells of Obese Prediabeticfa/fa Rats

Shimabukuro, M., Higa, M., Zhou, Y.-T., Wang, M.-Y., Newgard, C. B., & Unger, R. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32487 · Cited by 394 · see citing works

Hepatocyte Apoptosis, Expression of Death Receptors, and Activation of NF-κB in the Liver of Nonalcoholic and Alcoholic Steatohepatitis Patients

Ribeiro, P. S., Cortez‐Pinto, H., Solá, S., Castro, R. E., Ramalho, R. M., Baptista, A., de Moura, M. C., Camilo, M., & Rodrigues, C. M. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.40009.x · Cited by 392 · see citing works

CerS2 Haploinsufficiency Inhibits β-Oxidation and Confers Susceptibility to Diet-Induced Steatohepatitis and Insulin Resistance

Raichur, S., Wang, S. T., Chan, P. W., Li, Y., Ching, J., Chaurasia, B., Dogra, S. K., Öhman, M. K., Takeda, K., Sugii, S., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.10.007 · Cited by 385 · see citing works

JNK1 but not JNK2 promotes the development of steatohepatitis in mice

Schattenberg, J. M., Singh, R., Wang, Y., Lefkowitch, J. H., Rigoli, R. M., Scherer, P. E., & Czaja, M. J. (2006) · Hepatology · doi:10.1002/hep.20999 · Cited by 384 · see citing works

Biomarkers of NAFLD progression: a lipidomics approach to an epidemic

Gorden, D. L., Myers, D. S., Ivanova, P. T., Fahy, E., Maurya, M. R., Gupta, S., Min, J., Spann, N. J., McDonald, J. G., Kelly, S. L., et al. (2015) · Journal of Lipid Research · doi:10.1194/jlr.p056002 · Cited by 372 · see citing works

Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease

Satapathy, S. K., & Sanyal, A. J. (2015) · Seminars in Liver Disease · doi:10.1055/s-0035-1562943 · Cited by 372 · see citing works

Palmitic acid mediates hypothalamic insulin resistance by altering PKC-θ subcellular localization in rodents

Benoit, S. C., Kemp, C. J., Elias, C. F., Abplanalp, W., Herman, J. P., Migrenne, S., Lefevre, A.-L., Cruciani-Guglielmacci, C., Magnan, C., Yu, F., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36714 · Cited by 351 · see citing works

Targeted Induction of Ceramide Degradation Leads to Improved Systemic Metabolism and Reduced Hepatic Steatosis

Xia, J. Y., Holland, W. L., Kusminski, C. M., Sun, K., Sharma, A. X., Pearson, M. J., Sifuentes, A. J., McDonald, J. G., Gordillo, R., & Scherer, P. E. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.06.007 · Cited by 348 · see citing works

Protein kinase B/Akt at a glance

Fayard, E., Tintignac, L. A. J., Baudry, A., & Hemmings, B. A. (2005) · Journal of Cell Science · doi:10.1242/jcs.02724 · Cited by 336 · see citing works

Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice

Feldstein, A. E., Canbay, A. E., Guicciardi, M. E., Higuchi, H., Bronk, S. F., & Gores, G. J. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00460-4 · Cited by 317 · see citing works

The pan‐caspase inhibitor Emricasan ( IDN ‐6556) decreases liver injury and fibrosis in a murine model of non‐alcoholic steatohepatitis

Barreyro, F. J., Holod, S., Finocchietto, P. V., Camino, A. M., Aquino, J. B., Avagnina, A., Carreras, M. C., Poderoso, J. J., & Gores, G. J. (2014) · Liver International · doi:10.1111/liv.12570 · Cited by 295 · see citing works

Hepatocytes release ceramide-enriched pro-inflammatory extracellular vesicles in an IRE1α-dependent manner

Kakazu, E., Mauer, A. S., Yin, M., & Malhi, H. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m063412 · Cited by 280 · see citing works

Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes

Han, M. S., Park, S. Y., Shinzawa, K., Kim, S., Chung, K. W., Lee, J., Kwon, C. H. D., Lee, K., Lee, J.-H., Park, C. K., et al. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700184-jlr200 · Cited by 258 · see citing works

Saturated Fatty Acids Do Not Directly Stimulate Toll-Like Receptor Signaling

Erridge, C., & Samani, N. J. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.194050 · Cited by 258 · see citing works

Glucose, palmitate and pro-inflammatory cytokines modulate production and activity of a phagocyte-like NADPH oxidase in rat pancreatic islets and a clonal beta cell line

Morgan, D., Oliveira-Emilio, H. R., Keane, D., Hirata, A. E., Rocha, M., Bordin, S. A., Curi, R., Newsholme, P., & Carpinelli, Â. R. (2006) · Diabetologia · doi:10.1007/s00125-006-0462-6 · Cited by 254 · see citing works

Palmitoleate attenuates palmitate-induced Bim and PUMA up-regulation and hepatocyte lipoapoptosis

Akazawa, Y., Cazanave, S. C., Mott, J. L., Elmi, N. A., Bronk, S. F., Kohno, S., Charlton, M., & Gores, G. J. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.01.003 · Cited by 252 · see citing works

An interconnected hierarchical model of cell death regulation by the BCL-2 family

Chen, H.-C., Kanai, M., Inoue-Yamauchi, A., Tu, H.-C., Huang, Y., Ren, D., Kim, H., Takeda, S., Reyna, D. E., Chan, P. M., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3236 · Cited by 249 · see citing works

REVIEW: Nonalcoholic steatohepatitis

Ludwig, J., McGill, D. B., & Lindor, K. D. (1997) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1997.tb00450.x · Cited by 247 · see citing works

Hepatocellular ballooning in NASH

Caldwell, S. H., Ikura, Y., Dias, D., Isomoto, K., Yabu, A., Moskaluk, C. A., Pramoonjago, P., Simmons, W., Scruggs, H., Rosenbaum, N., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.031 · Cited by 244 · see citing works

Ballooned hepatocytes in steatohepatitis: The value of keratin immunohistochemistry for diagnosis

Lackner, C., Gogg-Kamerer, M., Zatloukal, K., Stumptner, C., Brunt, E. M., & Denk, H. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.026 · Cited by 240 · see citing works

Nuclear factor high-mobility group box1 mediating the activation of toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice

Li, L., Chen, L., Hu, L., Liu, Y., Sun, H., Tang, J. P., Hou, Y.-J., Chang, Y., Tu, Q., Feng, G., et al. (2011) · Hepatology · doi:10.1002/hep.24552 · Cited by 236 · see citing works

Mixed lineage kinase 3 mediates release of C‐X‐C motif ligand 10–bearing chemotactic extracellular vesicles from lipotoxic hepatocytes

Ibrahim, S. H., Hirsova, P., Tomita, K., Bronk, S. F., Werneburg, N. W., Harrison, S. A., Goodfellow, V. S., Malhi, H., & Gores, G. J. (2016) · Hepatology · doi:10.1002/hep.28252 · Cited by 232 · see citing works

Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance†

Singh, R., Wang, Y., Xiang, Y., Tanaka, K. E., Gaarde, W. A., & Czaja, M. J. (2008) · Hepatology · doi:10.1002/hep.22578 · Cited by 224 · see citing works

Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis

Kakisaka, K., Cazanave, S. C., Fingas, C. D., Guicciardi, M. E., Bronk, S. F., Werneburg, N. W., Mott, J. L., & Gores, G. J. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00301.2011 · Cited by 222 · see citing works

Roles for C16-ceramide and Sphingosine 1-Phosphate in Regulating Hepatocyte Apoptosis in Response to Tumor Necrosis Factor-α

Osawa, Y., Uchinami, H., Bielawski, J., Schwabe, R. F., Hannun, Y. A., & Brenner, D. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503002200 · Cited by 221 · see citing works

Lipid-Induced Hepatocyte-Derived Extracellular Vesicles Regulate Hepatic Stellate Cells via MicroRNA Targeting Peroxisome Proliferator-Activated Receptor-γ

Povero, D., Panera, N., Eguchi, A., Johnson, C. D., Papouchado, B. G., de Araujo Horcel, L., Pinatel, E. M., Alisi, A., Nobili, V., & Feldstein, A. E. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.07.007 · Cited by 221 · see citing works

Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease

Guy, C. D., Suzuki, A., Zdanowicz, M., Abdelmalek, M. F., Burchette, J. L., Ünalp, A., & Diehl, A. M. (2011) · Hepatology · doi:10.1002/hep.25559 · Cited by 217 · see citing works

Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity

Malhi, H., Barreyro, F. J., Isomoto, H., Bronk, S. F., & Gores, G. J. (2007) · Gut · doi:10.1136/gut.2006.118059 · Cited by 212 · see citing works

Lipid-Induced Toxicity Stimulates Hepatocytes to Release Angiogenic Microparticles That Require Vanin-1 for Uptake by Endothelial Cells

Povero, D., Eguchi, A., Niesman, I. R., Andronikou, N., du Jeu, X. D. M., Mulya, A., Berk, M. P., Lazić, M., Thapaliya, S., Parola, M., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004512 · Cited by 207 · see citing works

Increased production of sonic hedgehog by ballooned hepatocytes

Rangwala, F., Guy, C. D., Lu, J., Suzuki, A., Burchette, J. L., Abdelmalek, M. F., Chen, W., & Diehl, A. M. (2011) · The Journal of Pathology · doi:10.1002/path.2888 · Cited by 201 · see citing works

The PPARα-FGF21 Hormone Axis Contributes to Metabolic Regulation by the Hepatic JNK Signaling Pathway

Vernia, S., Cavanagh, J., García-Haro, L., Sabio, G., Barrett, T., Jung, D. Y., Kim, J. K., Xu, J. L., Shulha, H. P., Garber, M. G., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.06.010 · Cited by 200 · see citing works

c-Jun N-terminal Kinase-1 From Hematopoietic Cells Mediates Progression From Hepatic Steatosis to Steatohepatitis and Fibrosis in Mice

Kodama, Y., Kisseleva, T., Iwaisako, K., Miura, K., Taura, K., Minicis, S. D., Österreicher, C. H., Schnabl, B., Seki, E., & Brenner, D. A. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.045 · Cited by 195 · see citing works

JNK1-dependent PUMA Expression Contributes to Hepatocyte Lipoapoptosis

Cazanave, S. C., Mott, J. L., Elmi, N. A., Bronk, S. F., Werneburg, N. W., Akazawa, Y., Kahraman, A., Garrison, S. P., Zambetti, G. P., Charlton, M., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.022491 · Cited by 191 · see citing works

Transcriptional Regulation of Bim by FoxO3A Mediates Hepatocyte Lipoapoptosis

Barreyro, F. J., Kobayashi, S., Bronk, S. F., Werneburg, N. W., Malhi, H., & Gores, G. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704391200 · Cited by 190 · see citing works

CHOP and AP-1 cooperatively mediate PUMA expression during lipoapoptosis

Cazanave, S. C., Elmi, N. A., Akazawa, Y., Bronk, S. F., Mott, J. L., & Gores, G. J. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00091.2010 · Cited by 190 · see citing works

Death Receptor-Mediated Cell Death and Proinflammatory Signaling in Nonalcoholic Steatohepatitis

Hirsova, P., & Gores, G. (2014) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2014.11.005 · Cited by 184 · see citing works

Bax inhibition protects against free fatty acid-induced lysosomal permeabilization

Feldstein, A. E., Werneburg, N. W., Li, Z., Bronk, S. F., & Gores, G. J. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00509.2005 · Cited by 174 · see citing works

Linking endoplasmic reticulum stress to cell death in hepatocytes: roles of C/EBP homologous protein and chemical chaperones in palmitate-mediated cell death

Pfaffenbach, K. T., Gentile, C. L., Nivala, A. M., Wang, D., Wei, Y., & Pagliassotti, M. J. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00642.2009 · Cited by 172 · see citing works

A Role for Protein Phosphatase 2A–Like Activity, but Not Atypical Protein Kinase Cζ, in the Inhibition of Protein Kinase B/Akt and Glycogen Synthesis by Palmitate

Cazzolli, R., Carpenter, L., Biden, T. J., & Schmitz‐Peiffer, C. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2210 · Cited by 156 · see citing works

Increased Diacylglycerols Characterize Hepatic Lipid Changes in Progression of Human Nonalcoholic Fatty Liver Disease; Comparison to a Murine Model

Gorden, D. L., Ivanova, P. T., Myers, D. S., McIntyre, J. O., VanSaun, M. N., Wright, J. K., Matrisian, L. M., & Brown, H. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022775 · Cited by 155 · see citing works

Sterol and Diacylglycerol Acyltransferase Deficiency Triggers Fatty Acid-mediated Cell Death

Garbarino, J., Padamsee, M., Wilcox, L. J., Oelkers, P. M., D’Ambrosio, D. N., Ruggles, K. V., Ramsey, N., Jabado, O., Turkish, A. R., & Sturley, S. L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.050443 · Cited by 149 · see citing works

Immature myeloid cells induced by a high-fat diet contribute to liver inflammation #

Deng, Z., Liu, Y., Liu, C., Xiang, X., Wang, J., Cheng, Z., Shah, S. V., Zhang, S., Zhang, L., Zhuang, X., et al. (2009) · Hepatology · doi:10.1002/hep.23148 · Cited by 149 · see citing works

Origin and evolution of TNF and TNF receptor superfamilies

Wiens, G. D., & Glenney, G. W. (2011) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2011.03.031 · Cited by 145 · see citing works

Increased hepatotoxicity of tumor necrosis factor–related apoptosis-inducing ligand in diseased human liver

Volkmann, X., Fischer, U., Bahr, M. J., Ott, M., Lehner, F., MacFarlane, M., Cohen, G. M., Manns, M. P., Schulze‐Osthoff, K., & Bantel, H. (2007) · Hepatology · doi:10.1002/hep.21846 · Cited by 141 · see citing works

Saturated, but Not Unsaturated, Fatty Acids Induce Apoptosis of Human Coronary Artery Endothelial Cells via Nuclear Factor-κB Activation

Staiger, K., Staiger, H., Weigert, C., Haas, C., Häring, H., & Kellerer, M. (2006) · Diabetes · doi:10.2337/db06-0188 · Cited by 139 · see citing works

Death Receptor 5 Signaling Promotes Hepatocyte Lipoapoptosis

Cazanave, S. C., Mott, J. L., Bronk, S. F., Werneburg, N. W., Fingas, C. D., Meng, X. W., Finnberg, N. K., El‐Deiry, W. S., Kaufmann, S. H., & Gores, G. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.280420 · Cited by 133 · see citing works

Metabolic Stress Signaling Mediated by Mixed-Lineage Kinases

Jaeschke, A., & Davis, R. J. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.07.008 · Cited by 133 · see citing works

Gastric Bypass Surgery Reduces Plasma Ceramide Subspecies and Improves Insulin Sensitivity in Severely Obese Patients

Huang, H., Kasumov, T., Gatmaitan, P., Heneghan, H., Kashyap, S. R., Schauer, P. R., Brethauer, S. A., & Kirwan, J. P. (2011) · Obesity · doi:10.1038/oby.2011.107 · Cited by 113 · see citing works

Myristic acid potentiates palmitic acid-induced lipotoxicity and steatohepatitis associated with lipodystrophy by sustaning de novo ceramide synthesis

Martínez-Gili, L., Torres, S., Baulies, A., Alarcón‐Vila, C., Elena, M., Fabriàs, G., Casas, J., Caballería, J., Fernández-Checa, J. C., & García‐Ruiz, C. (2015) · Oncotarget · doi:10.18632/oncotarget.6286 · Cited by 107 · see citing works

Role of hepatocyte S6K1 in palmitic acid-induced endoplasmic reticulum stress, lipotoxicity, insulin resistance and in oleic acid-induced protection

Pardo, V., González‐Rodríguez, Á., Muntané, J., Kozma, S. C., & Valverde, Á. M. (2015) · Food and Chemical Toxicology · doi:10.1016/j.fct.2015.03.029 · Cited by 106 · see citing works

ASMase is required for chronic alcohol induced hepatic endoplasmic reticulum stress and mitochondrial cholesterol loading

Fernandez, A., Matías, N., Fucho, R., Ribas, V., von Montfort, C., Nuño‐Lámbarri, N., Baulies, A., Martínez-Gili, L., Tarrats, N., Marı́, M., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.05.023 · Cited by 103 · see citing works

TRAIL receptor deletion in mice suppresses the inflammation of nutrient excess

Idrissova, L., Malhi, H., Werneburg, N. W., LeBrasseur, N. K., Bronk, S. F., Fingas, C. D., Tchkonia, T., Pirtskhalava, T., White, T. A., Stout, M. B., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.11.033 · Cited by 95 · see citing works

Lack of Fas antagonism by Met in human fatty liver disease

Zou, C., Ma, J., Wang, X. B., Guo, L., Zhu, Z., Stoops, J. W., Eaker, A. E., Johnson, C. J., Strom, S. C., Michalopoulos, G. K., et al. (2007) · Nature Medicine · doi:10.1038/nm1625 · Cited by 95 · see citing works

A role for miR-296 in the regulation of lipoapoptosis by targeting PUMA

Cazanave, S. C., Mott, J. L., Elmi, N. A., Bronk, S. F., Masuoka, H. C., Charlton, M., & Gores, G. J. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m014654 · Cited by 93 · see citing works

Mixed Lineage Kinase 3 (MLK3)-activated p38 MAP Kinase Mediates Transforming Growth Factor-β-induced Apoptosis in Hepatoma Cells

Kim, K.-Y., Kim, B.-C., Xu, Z., & Kim, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313947200 · Cited by 93 · see citing works

Good fat/bad fat

McClain, C. J., Barve, S. S., & Deaciuc, I. V. (2007) · Hepatology · doi:10.1002/hep.21788 · Cited by 88 · see citing works

Vismodegib Suppresses TRAIL-mediated Liver Injury in a Mouse Model of Nonalcoholic Steatohepatitis

Hirsova, P., Ibrahim, S. H., Bronk, S. F., Yagita∥, H., & Gores, G. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070599 · Cited by 86 · see citing works

C/EBP Homologous Protein-induced Macrophage Apoptosis Protects Mice from Steatohepatitis

Malhi, H., Kropp, E. M., Clavo, V., Kobrossi, C. R., Han, J., Mauer, A. S., Yong, J., & Kaufman, R. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.442954 · Cited by 86 · see citing works

Inhibition of hedgehog signaling ameliorates hepatic inflammation in mice with nonalcoholic fatty liver disease

Kwon, H., Song, K., Han, C. L., Chen, W., Wang, Y., Dash, S., Lim, K., & Wu, T. (2015) · Hepatology · doi:10.1002/hep.28289 · Cited by 86 · see citing works

Sphingosine mediates TNFα-induced lysosomal membrane permeabilization and ensuing programmed cell death in hepatoma cells

Ullio, C., Casas, J., Brunk, U. T., Sala, G. L., Fabriàs, G., Ghidoni, R., Bonelli, G., Baccino, F. M., & Autelli, R. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m022384 · Cited by 84 · see citing works

Cdc42 and Rac1 are major contributors to the saturated fatty acid-stimulated JNK pathway in hepatocytes

Sharma, M., Urano, F., & Jaeschke, A. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.03.019 · Cited by 83 · see citing works

Activation of mammalian target of rapamycin complex 1 and insulin resistance induced by palmitate in hepatocytes

Mordier, S. B., & Iynedjian, P. B. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.004 · Cited by 82 · see citing works

Double-Stranded RNA-Activated Protein Kinase Is a Key Modulator of Insulin Sensitivity in Physiological Conditions and in Obesity in Mice

Carvalho-Filho, M. A., Carvalho, B. M., Oliveira, A. G., Guadagnini, D., Ueno, M., Dias, M. M., Tsukumo, D. M. L., Hirabara, S. M., Reis, L. F. L., Curi, R., et al. (2012) · Endocrinology · doi:10.1210/en.2012-1400 · Cited by 72 · see citing works

Fatty acid‐induced defects in insulin signalling, in myotubes derived from children, are related to ceramide production from palmitate rather than the accumulation of intramyocellular lipid

Sabin, M. A., Stewart, C. E. H., Crowne, E. C., Turner, S. J., Hunt, L. P., Welsh, G. I., Grohmann, M. J., Holly, J. M. P., & Shield, J. P. H. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.20922 · Cited by 71 · see citing works

A hedgehog survival pathway in ‘undead’ lipotoxic hepatocytes

Kakisaka, K., Cazanave, S. C., Werneburg, N. W., Razumilava, N., Mertens, J. C., Bronk, S. F., & Gores, G. J. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.05.011 · Cited by 65 · see citing works

Genetics, diagnostics and therapeutic advances in NAFLD

Rinella, M. E., & Sanyal, A. J. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2014.232 · Cited by 65 · see citing works

Microparticles Mediate Hepatic Ischemia-Reperfusion Injury and Are the Targets of Diannexin (ASP8597)

Teoh, N., Ajamieh, H., Wong, H. J., Croft, K. D., Mori, T. A., ALLISON, A. C., & Farrell, G. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104376 · Cited by 56 · see citing works

Diet-induced obesity mediated by the JNK/DIO2 signal transduction pathwayPreprint

Vernia, S., Cavanagh, J., Barrett, T., Jung, D. Y., Kim, J. K., & Davis, R. J. (2013) · Genes & Development · doi:10.1101/gad.223800.113 · Cited by 55 · see citing works

Mixed lineage kinase 3 deficient mice are protected against the high fat high carbohydrate diet‐induced steatohepatitis

Ibrahim, S. H., Gores, G. J., Hirsova, P., Kirby, M., Miles, L., Jaeschke, A., & Kohli, R. (2013) · Liver International · doi:10.1111/liv.12353 · Cited by 54 · see citing works

Wogonin ameliorates lipotoxicity-induced apoptosis of cultured vascular smooth muscle cells via interfering with DAG-PKC pathway

Liu, Y., Wang, X., Ahmed, N., Kong, Z., Hong, Y., Wang, C., & Zhang, J. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.120 · Cited by 54 · see citing works

Acute reversal of lipid-induced muscle insulin resistance is associated with rapid alteration in PKC-θ localization

Bell-Anderson, K. S., Schmitz‐Peiffer, C., Lim-Fraser, M., Biden, T. J., Cooney, G. J., & Kraegen, E. W. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.5.e1196 · Cited by 53 · see citing works

Degradation of Keap1 activates BH3-only proteins Bim and PUMA during hepatocyte lipoapoptosis

Cazanave, S. C., Wang, X., Zhou, H., Rahmani, M., Grant, S., Durrant, D., Klaassen, C. D., Yamamoto, M. P., & Sanyal, A. J. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.49 · Cited by 48 · see citing works

Mcl-1 Degradation during Hepatocyte Lipoapoptosis

Masuoka, H. C., Mott, J. L., Bronk, S. F., Werneburg, N. W., Akazawa, Y., Kaufmann, S. H., & Gores, G. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.039545 · Cited by 42 · see citing works

iPLA2β deficiency attenuates obesity and hepatic steatosis in ob / ob mice through hepatic fatty-acyl phospholipid remodeling

Deng, X., Wang, J., Li, J., Utaipan, T., Tuma‐Kellner, S., Schmitz, G., Liebisch, G., Stremmel, W., & Chamulitrat, W. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.02.004 · Cited by 41 · see citing works

Inhibitory effect on protein kinase Cθ by Crocetin attenuates palmitate-induced insulin insensitivity in 3T3-L1 adipocytes

Yang, L., Qian, Z., Ji, H., Yang, R., Wang, Y., Liang, X., Sheng, L., Zhao, B., & Zhang, X. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.05.061 · Cited by 38 · see citing works

Plasma membrane phospholipase A 2 controls hepatocellular fatty acid uptake and is responsive to pharmacological modulation: implications for nonalcoholic steatohepatitis

Stremmel, W., Staffer, S., Wannhoff, A., Pathil, A., & Chamulitrat, W. (2014) · The FASEB Journal · doi:10.1096/fj.14-249763 · Cited by 37 · see citing works

PKR is not obligatory for high-fat diet-induced obesity and its associated metabolic and inflammatory complications

Lancaster, G. I., Kammoun, H. L., Kraakman, M. J., Kowalski, G. M., Bruce, C. R., & Febbraio, M. A. (2016) · Nature Communications · doi:10.1038/ncomms10626 · Cited by 30 · see citing works

Silymarin Prevents Palmitate‐Induced Lipotoxicity in HepG2 Cells: Involvement of Maintenance of Akt Kinase Activation

Song, Z., Song, M., Lee, D. Y. W., Liu, Y., Deaciuc, I. V., & McClain, C. J. (2007) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2007.00116.x · Cited by 29 · see citing works

Amplification of CD95 Activation by Caspase 8-induced Endosomal Acidification in Rat Hepatocytes

Reinehr, R., Sommerfeld, A., Keitel, V., Grether‐Beck, S., & Häussinger, D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706853200 · Cited by 24 · see citing works

MICRORNAs IN ER STRESS: DIVERGENT ROLES IN CELL FATE DECISIONS

Malhi, H. (2014) · Current Pathobiology Reports · doi:10.1007/s40139-014-0046-y · Cited by 23 · see citing works

Enhanced Sensitivity to CD95-Induced Apoptosis in ob/ob Mice

Siebler, J., Schuchmann, M., Strand, S., Lehr, H. A., Neurath, M. F., & Galle, P. R. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9148-7 · Cited by 15 · see citing works

Inhibition of protein kinase B by palmitate in the insulin signaling of HepG2 cells and the preventive effect of arachidonic acid on insulin resistance

Xia, Y., Wan, X.-D., Duan, Q., He, S., & Wang, X. (2007) · Frontiers of Medicine · doi:10.1007/s11684-007-0038-y · Cited by 3 · see citing works

Mechanisms of NAFLD development and therapeutic strategies

Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0104-9 · Cited by 4,354 · see citing works

Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease.

Lebeaupin, C., Vallée, D., Hazari, Y., Hetz, C., Chevet, É., & Bailly-maitre, B. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.06.008 · Cited by 835 · see citing works

Triggering and resolution of inflammation in NASH

Schuster, S., Cabrera, D., Arrese, M., & Feldstein, A. E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0009-6 · Cited by 943 · see citing works

Lipotoxicity and the gut-liver axis in NASH pathogenesis

Marra, F., & Svegliati-Baroni, G. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.014 · Cited by 847 · see citing works

Molecular pathways of nonalcoholic fatty liver disease development and progression

Bessone, F., Razori, M. V., & Roma, M. G. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2947-0 · Cited by 624 · see citing works

Recent insights into the pathogenesis of nonalcoholic fatty liver disease

Arab, J. P., Arrese, M., & Trauner, M. (2018) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043617 · Cited by 573 · see citing works

Past, present and future perspectives in nonalcoholic fatty liver disease

Sanyal, A. J. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0144-8 · Cited by 522 · see citing works

Pathophysiology of obesity and its associated diseases

Jin, X., Qiu, T., Li, L., Yu, R., Chen, X., Li, C., Proud, C. G., & Jiang, T. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.01.012 · Cited by 552 · see citing works

Determinants of Fibrosis Progression and Regression in NASH

Schuppan, D., Surabattula, R., & Wang, X. Y. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.012 · Cited by 479 · see citing works

Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH

Pierantonelli, I., & Svegliati‐Baroni, G. (2018) · Transplantation · doi:10.1097/tp.0000000000002480 · Cited by 459 · see citing works

Non-alcoholic fatty liver disease

Neuschwander‐Tetri, B. A. (2017) · BMC Medicine · doi:10.1186/s12916-017-0806-8 · Cited by 452 · see citing works

How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?

Geng, Y., Faber, K., de Meijer, V. D., Blokzijl, H., & Moshage, H. (2021) · Hepatology International · doi:10.1007/s12072-020-10121-2 · Cited by 392 · see citing works

Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH)

Xu, X., Poulsen, K. L., Wu, L., Liu, S., Miyata, T., Song, Q., Wei, Q., Zhao, C., Lin, C., & Yang, J. B. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01119-3 · Cited by 370 · see citing works

Challenges and opportunities in NASH drug development

Harrison, S. A., Allen, A. M., Dubourg, J., Noureddin, M., & Alkhouri, N. (2023) · Nature Medicine · doi:10.1038/s41591-023-02242-6 · Cited by 353 · see citing works

Ferroptosis Affects the Progression of Nonalcoholic Steatohepatitis via the Modulation of Lipid Peroxidation–Mediated Cell Death in Mice

Qi, J., Kim, J.-W., Zhou, Z., Lim, C.-W., & Kim, B. (2020) · The American Journal of Pathology · doi:10.1016/j.ajpath.2019.09.011 · Cited by 338 · see citing works

High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms

Lian, C.-Y., Zhai, Z., Li, Z., & Wang, L. (2020) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109199 · Cited by 304 · see citing works

Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation

Ibrahim, S. H., Hirsova, P., & Gores, G. J. (2018) · Gut · doi:10.1136/gutjnl-2017-315691 · Cited by 278 · see citing works

Apoptosis and non-alcoholic fatty liver diseases

Kanda, T., Matsuoka, S., Yamazaki, M., Shibata, T., Nirei, K., Takahashi, H., Kaneko, T., Fujisawa, M., Higuchi, T., Nakamura, H., et al. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i25.2661 · Cited by 269 · see citing works

A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis

Harrison, S. A., Goodman, Z., Jabbar, A., Vemulapalli, R., Younes, Z. H., Freilich, B., Sheikh, M. Y., Schattenberg, J. M., Kayali, Z., Zivony, A., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.11.024 · Cited by 260 · see citing works

Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease

Svegliati‐Baroni, G., Pierantonelli, I., Torquato, P., Marinelli, R., Ferreri, C., Chatgilialoglu, C., Bartolini, D., & Galli, F. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.05.029 · Cited by 250 · see citing works

Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Lee, K., Wu, P.-S., & Lin, H. (2022) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0237 · Cited by 260 · see citing works

The circadian clock and liver function in health and disease

Mukherji, A., Bailey, S. M., Staels, B., & Baumert, T. F. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.03.020 · Cited by 246 · see citing works

Macrophage functional diversity in NAFLD — more than inflammation

Barreby, E., Chen, P., & Aouadi, M. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00675-6 · Cited by 246 · see citing works

Liver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategies

Parola, M., & Pinzani, M. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101231 · Cited by 226 · see citing works

Novel therapeutic targets for cholestatic and fatty liver disease

Trauner, M., & Fuchs, C. D. (2022) · Gut · doi:10.1136/gutjnl-2021-324305 · Cited by 204 · see citing works

IRE1A Stimulates Hepatocyte-Derived Extracellular Vesicles That Promote Inflammation in Mice With Steatohepatitis

Dasgupta, D., Nakao, Y., Mauer, A. S., Thompson, J., Sehrawat, T. S., Liao, C., Krishnan, A., Lucien, F., Guo, Q., Liu, M., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.06.031 · Cited by 188 · see citing works

Therapeutic Landscape for NAFLD in 2020

Neuschwander‐Tetri, B. A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.051 · Cited by 183 · see citing works

Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management

Cholankeril, G. T., Patel, R., Khurana, S., & Satapathy, S. K. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i11.533 · Cited by 185 · see citing works

Cell Culture Models of Fatty Acid Overload: Problems and Solutions

Alsabeeh, N., Chausse, B., Kakimoto, P. A., Kowaltowski, A. J., & Shirihai, O. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.11.006 · Cited by 167 · see citing works

Sphingolipids and glycerophospholipids – The “ying and yang” of lipotoxicity in metabolic diseases

Rodríguez‐Cuenca, S., Pellegrinelli, V., Campbell, M., Orešič, M., & Vidal‐Puig, A. (2017) · Progress in Lipid Research · doi:10.1016/j.plipres.2017.01.002 · Cited by 153 · see citing works

NAFLD: Reporting Histologic Findings in Clinical Practice

Brunt, E. M., Kleiner, D. E., Carpenter, D. H., Rinella, M. E., Harrison, S. A., Loomba, R. S., Younossi, Z. M., Neuschwander‐Tetri, B. A., & Sanyal, A. J. (2020) · Hepatology · doi:10.1002/hep.31599 · Cited by 153 · see citing works

Manifestations and mechanisms of myocardial lipotoxicity in obesity

Sletten, A. C., Peterson, L. R., & Schaffer, J. E. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12728 · Cited by 142 · see citing works

The unfolded protein response and hepatic lipid metabolism in non alcoholic fatty liver disease

Song, M. J., & Malhi, H. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107401 · Cited by 142 · see citing works

Metabolic Dysfunction–Associated Steatotic Liver Disease: From Pathogenesis to Current Therapeutic Options

Portincasa, P., Khalil, M., Mahdi, L., Perniola, V., Idone, V., Graziani, A., Baffy, G., & Ciaula, A. D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115640 · Cited by 152 · see citing works

Green Tea Polyphenol EGCG Alleviates Metabolic Abnormality and Fatty Liver by Decreasing Bile Acid and Lipid Absorption in Mice

Huang, J., Feng, S., Liu, A., Dai, Z., Wang, H., Reuhl, K. R., Lu, W., & Yang, C. S. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700696 · Cited by 140 · see citing works

Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source

Boland, M. L., Oró, D., Tølbøl, K. S., Thrane, S. T., Nielsen, J. C., Cohen, T. S., Tabor, D. E., Fernandes, F., Tovchigrechko, A., Veidal, S. S., et al. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i33.4904 · Cited by 129 · see citing works

Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity

INSERM, U., & Fromenty, B. (2017) · Journal of Clinical and Translational Research · doi:10.18053/jctres.03.2017s1.006 · Cited by 124 · see citing works

Unraveling the Role of Leptin in Liver Function and Its Relationship with Liver Diseases

Martinez‐Uña, M., López‐Mancheño, Y., Diéguez, C., Fernandez-Rojo, M. A., & Novelle, M. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249368 · Cited by 115 · see citing works

Macronutrients and the Adipose-Liver Axis in Obesity and Fatty Liver

Duwaerts, C. C., & Maher, J. J. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.02.001 · Cited by 109 · see citing works

Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease

Khambu, B., Yan, S., Huda, N., Liu, G., & Yin, X. (2018) · Liver Research · doi:10.1016/j.livres.2018.09.004 · Cited by 105 · see citing works

Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma

Kutlu, Ö., Kaleli, H. N., & Ozer, E. (2018) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2018/8543763 · Cited by 102 · see citing works

Hepatocyte-Derived Lipotoxic Extracellular Vesicle Sphingosine 1-Phosphate Induces Macrophage Chemotaxis

Liao, C., Song, M. J., Gao, Y., Mauer, A. S., Revzin, A., & Malhi, H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02980 · Cited by 99 · see citing works

Emerging role of aging in the progression of NAFLD to HCC

He, Y., Su, Y., Duan, C., Wang, S., He, W. G., Zhang, Y., An, X., & He, M. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101833 · Cited by 98 · see citing works

Integrated-gut-liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty liver disease

Yang, J., Hirai, Y., Iida, K., Ito, S., Trumm, M., Terada, S., Sakai, R., Tsuchiya, T., Tabata, O., & Kamei, K.-I. (2023) · Communications Biology · doi:10.1038/s42003-023-04710-8 · Cited by 98 · see citing works

Diet-induced gut dysbiosis and inflammation: Key drivers of obesity-driven NASH

Kang, G. G., Trevaskis, N. L., Murphy, A. J., & Febbraio, M. A. (2023) · iScience · doi:10.1016/j.isci.2022.105905 · Cited by 94 · see citing works

Role of Leptin in Non-Alcoholic Fatty Liver Disease

Jiménez‐Cortegana, C., García-Galey, A., Tami, M., Bellido, P. D. P., Carmona, I., López, S., Álba, G., & Sánchez‐Margalet, V. (2021) · Biomedicines · doi:10.3390/biomedicines9070762 · Cited by 96 · see citing works

From gut to liver: Exploring the crosstalk between gut-liver axis and oxidative stress in metabolic dysfunction-associated steatotic liver disease

Zhou, M., Lv, J., Chen, X., Shi, Y., Chao, G., & Zhang, S. (2025) · Annals of Hepatology · doi:10.1016/j.aohep.2025.101777 · Cited by 96 · see citing works

Cellular stress in the pathogenesis of nonalcoholic steatohepatitis and liver fibrosis

Sharma, S. K., Guillou, D. L., & Chen, J. Y. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00832-w · Cited by 95 · see citing works

Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD).

Iturbe-Rey, S., Maccali, C., Arrese, M., Aspichueta, P., Oliveira, C. P., Castro, R. E., Lapitz, A., Izquierdo-Sánchez, L., Bujanda, L., Perugorria, M. J., et al. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.119053 · Cited by 104 · see citing works

The metabolic basis of nonalcoholic steatohepatitis

Chakravarthy, M. V., & Neuschwander‐Tetri, B. A. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.112 · Cited by 87 · see citing works

Emerging Role of Hepatic Ketogenesis in Fatty Liver Disease

Mooli, R. G. R., & Ramakrishnan, S. K. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.946474 · Cited by 84 · see citing works

CD47-SIRPα axis blockade in NASH promotes necroptotic hepatocyte clearance by liver macrophages and decreases hepatic fibrosis

Shi, H., Wang, X., Li, F., Gerlach, B. D., Yurdagul, A., Moore, M. P., Zeldin, S., Zhang, H., Cai, B., Zheng, Z., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abp8309 · Cited by 85 · see citing works

Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research

Berardo, C., Pasqua, L. G. D., Cagna, M., Richelmi, P., Vairetti, M., & Ferrigno, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249646 · Cited by 80 · see citing works

To die or not to die: death signaling in nonalcoholic fatty liver disease

Akazawa, Y., & Nakao, K. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-018-1451-5 · Cited by 79 · see citing works

Hepatocyte TNF Receptor–Associated Factor 6 Aggravates Hepatic Inflammation and Fibrosis by Promoting Lysine 6–Linked Polyubiquitination of Apoptosis Signal‐Regulating Kinase 1

Wang, Y., Wen, H., Fu, J., Cai, L., Li, P., Zhao, C., Dong, Z., Ma, J., Wang, X., Tian, H., et al. (2019) · Hepatology · doi:10.1002/hep.30822 · Cited by 79 · see citing works

Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link

Chrysavgis, L., Giannakodimos, I., Diamantopoulou, P., & Cholongitas, E. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i3.310 · Cited by 67 · see citing works

Differential Lipotoxic Effects of Palmitate and Oleate in Activated Human Hepatic Stellate Cells and Epithelial Hepatoma Cells

Hetherington, A. M., Sawyez, C. G., Zilberman, E., Stoianov, A. M., Robson, D. L., & Borradaile, N. M. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000447866 · Cited by 77 · see citing works

Pathogenesis of Nonalcoholic Steatohepatitis and Hormone-Based Therapeutic Approaches

Kim, K. H., & Lee, M. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00485 · Cited by 77 · see citing works

Caspase-11 promotes high-fat diet-induced NAFLD by increasing glycolysis, OXPHOS, and pyroptosis in macrophages

Drummer, C., Saaoud, F., Jhala, N. C., Cueto, R., Sun, Y., Xu, K., Shao, Y., Lu, Y., Shen, H., Yang, L., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1113883 · Cited by 77 · see citing works

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Cha, J.-Y., Kim, D.-H., & Chun, K. (2018) · Laboratory Animal Research · doi:10.5625/lar.2018.34.4.133 · Cited by 71 · see citing works

Advancing the understanding of NAFLD to hepatocellular carcinoma development: From experimental models to humans

Chen, K., Ma, J., Jia, X., Ai, W., Ma, Z., & Pan, Q. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.11.005 · Cited by 70 · see citing works

Lipotoxicity as the Leading Cause of Non-Alcoholic Steatohepatitis

Branković, M., Jovanović, I., Dukić, M., Radonjić, T., Oprić, S., Klašnja, S., & Zdravkovic, M. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095146 · Cited by 67 · see citing works

Lipotoxicity: Many Roads to Cell Dysfunction and Cell Death: Introduction to a Thematic Review Series

Schaffer, J. E. (2016) · Journal of Lipid Research · doi:10.1194/jlr.e069880 · Cited by 65 · see citing works

Upregulation of miR-96-5p by bone marrow mesenchymal stem cells and their exosomes alleviate non-alcoholic steatohepatitis: Emphasis on caspase-2 signaling inhibition

El-Derany, M. O., & AbdelHamid, S. G. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114624 · Cited by 64 · see citing works

p53 as a Dichotomous Regulator of Liver Disease: The Dose Makes the Medicine

Krstić, J., Galhuber, M., Schulz, T. J., Schupp, M., & Prokesch, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030921 · Cited by 63 · see citing works

Characterization of Cellular Sources and Circulating Levels of Extracellular Vesicles in a Dietary Murine Model of Nonalcoholic Steatohepatitis

Li, J., Liu, H., Mauer, A. S., Lucien, F., Raiter, A. M., Bandla, H., Mounajjed, T., Yin, Z., Glaser, K. J., Yin, M., et al. (2019) · Hepatology Communications · doi:10.1002/hep4.1404 · Cited by 63 · see citing works

Extracellular Vesicles as Inflammatory Drivers in NAFLD

Srinivas, A. N., Suresh, D., Santhekadur, P. K., Suvarna, D., & Kumar, D. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.627424 · Cited by 62 · see citing works

Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets

Chen, Y.-S., Wang, W., Morgan, M., Robson, T., & Annett, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1148934 · Cited by 63 · see citing works

Identification of the genomic region under epigenetic regulation during non‐alcoholic fatty liver disease progression

Hotta, K., Kitamoto, T., Kitamoto, A., Ogawa, Y., Honda, Y., Kessoku, T., Yoneda, M., Imajo, K., Tomeno, W., Saito, S., et al. (2017) · Hepatology Research · doi:10.1111/hepr.12992 · Cited by 59 · see citing works

Diosgenin attenuates non-alcoholic fatty liver disease in type 2 diabetes through regulating SIRT6-related fatty acid uptake

Nie, K., Gao, Y., Chen, S., Wang, Z., Wang, H., Tang, Y., Su, H., Lu, F., Dong, H., & Fang, K. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154661 · Cited by 62 · see citing works

Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: From Epidemiology to Diagnostic Approach

Grgurević, I., Božin, T., Mikuš, M., Kukla, M., & O’Beirne, J. P. (2021) · Cancers · doi:10.3390/cancers13225844 · Cited by 58 · see citing works

Treating inflammation to combat non-alcoholic fatty liver disease

Wiering, L., & Tacke, F. (2022) · Journal of Endocrinology · doi:10.1530/joe-22-0194 · Cited by 58 · see citing works

ENO3 promoted the progression of NASH by negatively regulating ferroptosis via elevation of GPX4 expression and lipid accumulation

Lü, D., Xia, Q., Yang, Z., Gao, S., Sun, S., Luo, X., Li, Z., Zhang, X., Han, S., Li, X., et al. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-471 · Cited by 51 · see citing works

Attenuating Effects of Dieckol on High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease by Decreasing the NLRP3 Inflammasome and Pyroptosis

Oh, S., Son, M., Byun, K.-A., Jang, J. T., Choi, C. H., Son, K. H., & Byun, K. (2021) · Marine Drugs · doi:10.3390/md19060318 · Cited by 51 · see citing works

A Regulatory Role of Apoptosis Antagonizing Transcription Factor in the Pathogenesis of Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma

Kumar, D. P., Santhekadur, P. K., Seneshaw, M., Mirshahi, F., Uram–Tuculescu, C., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.30346 · Cited by 50 · see citing works

Mitochondrial protease ClpP supplementation ameliorates diet-induced NASH in mice

Choi, S., Hwang, Y., Lee, S., Jung, H.-K., Shin, T. H., Son, Y., Park, S., Han, S. J., Kim, H. J., Lee, K. W., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.03.034 · Cited by 48 · see citing works

Non-Alcoholic Fatty Liver Disease (NAFLD) and Bariatric/Metabolic Surgery as Its Treatment Option: A Review

Głuszyńska, P., Lemancewicz, D., Dzięcioł, J. B., & Hady, H. R. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10245721 · Cited by 47 · see citing works

MRG15 aggravates non-alcoholic steatohepatitis progression by regulating the mitochondrial proteolytic degradation of TUFM

Tian, C., Min, X., Zhao, Y., Wang, Y., Wu, X., Liu, S., Dou, W., Zhou, T., Liu, Y., Luo, R., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.07.017 · Cited by 47 · see citing works

Antifibrotic therapies for metabolic dysfunction-associated steatotic liver disease

Schwabe, R. F., Tacke, F., Sugimoto, A., & Friedman, S. L. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101421 · Cited by 50 · see citing works

Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma

Raza, S., Rajak, S., Anjum, B., & Sinha, R. A. (2019) · Hepatoma Research · doi:10.20517/2394-5079.2019.014 · Cited by 47 · see citing works

Changes in Key Mitochondrial Lipids Accompany Mitochondrial Dysfunction and Oxidative Stress in NAFLD

Durand, M., Coué, M., Croyal, M., Moyon, T., Tesse, A., Atger, F., Ouguerram, K., & Jacobi, D. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9986299 · Cited by 44 · see citing works

Nonalcoholic Steatohepatitis Drug Development Pipeline: An Update

Chew, N., Ng, C. H., Truong, E., Noureddin, M., & Kowdley, K. V. (2022) · Seminars in Liver Disease · doi:10.1055/a-1877-9656 · Cited by 43 · see citing works

Bridging the gap in obesity research: A consensus statement from the European Society for Clinical Investigation

Carbone, F., Després, J., Ioannidis, J. P. A., Neeland, I. J., Garruti, G., Busetto, L., Liberale, L., Ministrini, S., Vilahur, G., Schindler, T. H., et al. (2025) · European Journal of Clinical Investigation · doi:10.1111/eci.70059 · Cited by 45 · see citing works

Phenotypes of Metabolic Dysfunction–Associated Steatotic Liver Disease–Associated Hepatocellular Carcinoma

Rivera‐Esteban, J., Muñoz, S., Higuera, M., Sena, E., Bermúdez-Ramos, M., Bañares, J., Martínez-Gómez, M., Cusidó, M. S., Jiménez-Masip, A., Francque, S., et al. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.03.028 · Cited by 45 · see citing works

TRAIL deletion prevents liver inflammation but not adipose tissue inflammation during murine diet‐induced obesity

Hirsova, P., Weng, P., Salim, W., Bronk, S. F., Griffith, T. S., Ibrahim, S. H., & Gores, G. J. (2017) · Hepatology Communications · doi:10.1002/hep4.1069 · Cited by 41 · see citing works

Integrating the contributions of mitochondrial oxidative metabolism to lipotoxicity and inflammation in NAFLD pathogenesis

Hughey, C. C., Puchalska, P., & Crawford, P. A. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159209 · Cited by 42 · see citing works

Unveiling the Role of the Fatty Acid Binding Protein 4 in the Metabolic-Associated Fatty Liver Disease

Moreno‐Vedia, J., Girona, J., Ibarretxe, D., Masana, L., & Rodríguez‐Calvo, R. (2022) · Biomedicines · doi:10.3390/biomedicines10010197 · Cited by 40 · see citing works

Scutellarin ameliorates hepatic lipid accumulation by enhancing autophagy and suppressing IRE1α / XBP1 pathway

Zhang, X., Huo, Z., Luan, H., Huang, Y., Shen, Y., Sheng, L., Liang, J.-Y., & Wu, F. (2021) · Phytotherapy Research · doi:10.1002/ptr.7344 · Cited by 39 · see citing works

Role of Extracellular Vesicles in the Pathophysiology, Diagnosis and Tracking of Non-Alcoholic Fatty Liver Disease

Newman, L. A., Sorich, M. J., & Rowland, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072032 · Cited by 39 · see citing works

Role of the type 3 cytokines IL-17 and IL-22 in modulating metabolic dysfunction-associated steatotic liver disease

Abdelnabi, M. N., Hassan, G. S., & Shoukry, N. H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1437046 · Cited by 38 · see citing works

Non-alcoholic fatty liver disease: Insights from sphingolipidomics

Montefusco, D. J., Allegood, J. C., Spiegel, S., & Cowart, L. A. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.05.078 · Cited by 38 · see citing works

Identification of transcriptomic signatures and crucial pathways involved in non-alcoholic steatohepatitis

He, W., Huang, C., Zhang, X., Wang, D., Chen, Y.-L., Zhao, Y., & Li, X. (2021) · Endocrine · doi:10.1007/s12020-021-02716-y · Cited by 38 · see citing works

Molecular pathogenesis: Connections between viral hepatitis-induced and non-alcoholic steatohepatitis-induced hepatocellular carcinoma

Tian, Z., Chen, X., Yang, P., Lin, Z., Wu, W., Zhang, W., Ding, J. H., Ding, R., Zhang, X., & Dou, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.984728 · Cited by 35 · see citing works

Hepatocellular carcinoma: pathogenesis, molecular mechanisms, and treatment advances

Ding, Z., Wang, L., Sun, J., Zheng, L., Tang, Y., & Tang, H. H. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1526206 · Cited by 35 · see citing works

Fecal microbiota transplantation: a promising strategy in preventing the progression of non-alcoholic steatohepatitis and improving the anti-cancer immune response

Delaune, V., Orci, L. A., Lacotte, S., Peloso, A., Schrenzel, J., Lazarević, V., & Toso, C. (2018) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2018.1518424 · Cited by 46 · see citing works

Network Modeling Approaches and Applications to Unravelling Non-Alcoholic Fatty Liver Disease

Blencowe, M., Karunanayake, T., Wier, J. R., Hsu, N., & Yang, X. (2019) · Genes · doi:10.3390/genes10120966 · Cited by 35 · see citing works

Mediterranean Diet: The Beneficial Effects of Lycopene in Non-Alcoholic Fatty Liver Disease

Abenavoli, L., Procopio, A. C., Paravati, M. R., Costa, G., Milić, N., Alcaro, S., & Luzza, F. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11123477 · Cited by 36 · see citing works

Mixed-lineage kinase 3 pharmacological inhibition attenuates murine nonalcoholic steatohepatitis

Tomita, K., Kohli, R., MacLaurin, B. L., Hirsova, P., Guo, Q., Sanchez, L. H. G., Gelbard, H. A., Blaxall, B. C., & Ibrahim, S. H. (2017) · JCI Insight · doi:10.1172/jci.insight.94488 · Cited by 34 · see citing works

Detection of DNA damage response in nonalcoholic fatty liver disease via p53-binding protein 1 nuclear expression

Akazawa, Y., Nakashima, R., Matsuda, K., Okamaoto, K., Hirano, R., Kawasaki, H., Miuma, S., Miyaaki, H., Malhi, H., Abiru, S., et al. (2019) · Modern Pathology · doi:10.1038/s41379-019-0218-8 · Cited by 34 · see citing works

Exercise activates Sirt1-mediated Drp1 acetylation and inhibits hepatocyte apoptosis to improve nonalcoholic fatty liver disease

Hu, Z., Zhang, H., Wang, Y., Li, B., Liu, K., Ran, J., & Li, L. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01798-z · Cited by 33 · see citing works

Lipotoxicity pathways intersect in hepatocytes: Endoplasmic reticulum stress, c‐Jun N‐terminal kinase‐1, and death receptors

Akazawa, Y., & Nakao, K. (2016) · Hepatology Research · doi:10.1111/hepr.12658 · Cited by 25 · see citing works

Pathogenic role of lipids in non-alcoholic fatty liver disease

Shulpekova, Y. O. (2012) · DOAJ (DOAJ: Directory of Open Access Journals)

Hepatocyte Lethal and Nonlethal Lipotoxic Injury

Hirsova, P., Ibrahim, S. H., Malhi, H., & Gores, G. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-53774-0_5 · Cited by 3 · see citing works

Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation

Ibrahim, S. H., Hirsova, P., & Gores, G. J. (2018) · Gut · doi:10.1136/gutjnl-2017-315691 · Cited by 278 · see citing works

Death Receptor-Mediated Cell Death and Proinflammatory Signaling in Nonalcoholic Steatohepatitis

Hirsova, P., & Gores, G. (2014) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2014.11.005 · Cited by 184 · see citing works